Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer

Go back to Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
AGENUS (NASDAQ: AGEN) Delayed: 6.68 +0.18 (2.77%)
Previous Close $6.50    52 Week High $7.49 
Open $6.52    52 Week Low $2.61 
Day High $6.99    P/E N/A 
Day Low $6.51    EPS $-1.10 
Volume 815,432       

(NASDAQ: GANX) Delayed: 1.33 +0.01 (0.76%)
Previous Close $1.32    52 Week High $ 
Open $1.32    52 Week Low $ 
Day High $1.41    P/E N/A 
Day Low $1.31    EPS $ 
Volume 510,726